Nuvation Bio Inc Class A (NUVB)
Deferred Revenue
$8.86M
Quarterly · Period ending: · USD
NUVB Deferred Revenue
Latest reported$8.86Mperiod ending
Latest reported$8.86Mperiod ending
NUVB Quarterly Deferred Revenue ($0.00 → $8.86M)
Quarterly deferred revenue
High-resolution chart · PNG
NUVB deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 8,855,000 | |
| 0 | |
| 0 | |
| 6,721,000 | |
| 9,725,000 | |
| 10,769,000 | |
| 11,117,000 | |
| 12,942,000 | |
| 12,200,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |